Cite
HARVARD Citation
Sandborn, W. et al. (2014). Long‐term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7‐year results from the PRECiSE 3 study. Alimentary pharmacology & therapeutics. 40 (8), pp. 903-916. [Online].